We have previously shown that GHR inhibition sensitizes melanoma cells to paclitaxel, as well as platinum-based antineoplastic drugs like cisplatin [18,69,70] and the pyrimidine analog, fluorouracil (5-FU) [70]. This evidence concerns the gene GHR and melanoma.